Image

Speech Accessibility Project: PD, MSA, PSP, LBD, CBD, Post DBS

Speech Accessibility Project: PD, MSA, PSP, LBD, CBD, Post DBS

Recruiting
18 years and older
All
Phase N/A

Overview

The goal of the Speech Accessibility Project at the University of Illinois Beckman Institute (https://speechaccessibilityproject.beckman.illinois.edu) is to collect, annotate, and curate a shared database of speech samples from people with disordered speech, and share this data set with researchers at other organizations. This project plans to collect 1,200,000 speech samples from 2,000 people, each of whom will provide 600 samples. 

The initial focus will be people with Parkinson's disease (PD), Multisystem Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Lewy Body Disease (LBD), Cortical Basal degeneration (CBD) and Post Deep Brain Stimulation (Post-DBS). 

UIUC will build an open-source software infrastructure to collect annotated speech samples and share these data in an appropriately secure fashion with researchers from our partner technology companies (and eventually, other organizations as well) so that they can use these data to improve their automatic speech recognition algorithms. This project promotes diversity, equity, and inclusion by helping technology companies to fully support all types of speech, and it is also more efficient and less burdensome for these specialized patient populations to have one centralized "collector" of speech samples.

Description

The goal of the entire project is to collect 1,200,000 speech samples from 2,000 people with dysarthria, where we expect to collect data from 400 people each from five different patient populations. Each person would provide 600 speech samples.
(600 samples/person x 400 persons/etiology x 5 etiologies = 1,200,000 samples)

Our schedule of research procedures is:
  1. March 2023-December 2024: data collection of speech samples from 400 people with PD and related disorders. 

Data collection of speech samples from the PD cohort will be a collaboration of the University of Illinois and of speech clinician mentors from LSVT Global (Lee Silverman Voice Treatment); data collection is virtual. 

Potential participants will be screened both with a questionnaire and by providing a short set of "quality control" speech samples. If the participant does not pass screening, they will be thanked for their interest. Otherwise, the participant is eligible for the study and can do the informed consent process and then engage in contributing speech samples.

Participants can do as many recordings as they wish on their home computer or smart phone at whatever time of day is convenient for them. Participants will be able to login to the system at any time, 24/7.

Participants have the opportunity to earn $180.00 and their helper can earn $90.00.

Participants also have the option to provide additional data about themselves, such as their age, race and ethnicity, and the year of their diagnosis. These "metadata tags" are completely optional but are helpful for analysis.

The collected speech samples will be stored securely in a custom database built by the UIUC Beckman Institute. All samples are stored with a unique participant ID code. All samples are annotated by our UIUC research team with technical information about the acoustic waveform and other information.

The entire database of speech samples will be shared with our coalition partners (Amazon, Apple, Google, Meta, and Microsoft), and, after all data collection is complete, with other universities and companies who are willing to sign our data use agreement. Each partner has signed a data use agreement with UIUC that allows these deidentified data to be used for improvements in speech recognition technology and assures the privacy of participants and confidentiality of data.

Eligibility

Inclusion Criteria:
  • Adult (age >= 18 years)
  • Self-reported diagnosis of: PD, MSA, PSP, LBD, CBD, Post-DBS
  • Reads and speaks English
  • Has a valid email address
  • Ability to access web browser to participate in the study
  • Is a resident of Canada or the United States (excluding the states of Illinois, Texas, and Washington)
Exclusion Criteria:
  • Is a resident of the State of Washington, Texas, or Illinois (because these states have privacy laws that would not allow us to collect 'voice prints')
  • If quality control screening of initial speech samples "fails" because of poor data quality (e.g., noisy recording environment)

Study details
    Parkinson Disease
    parkinson's disease
    Parkinson's disease
    PD
    Progressive Supranuclear Palsy
    PSP
    Multiple System Atrophy
    MSA
    Dementia With Lewy Bodies
    LBD
    CBD

NCT05889260

University of Illinois at Urbana-Champaign

23 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.